Should You Consider Buying Dentsply Sirona Stock After a Director Acquired 15,000 Shares?
Gregory T. Lucier Increases Stake in Dentsply Sirona
Gregory T. Lucier, who serves on the Board of Directors at Dentsply Sirona (NASDAQ: XRAY), recently acquired 15,000 shares of the company’s common stock. The average purchase price was $12.45 per share, with the transaction taking place on March 9, 2026, as disclosed in a SEC Form 4 filing.
Transaction Details
| Metric | Value |
|---|---|
| Shares Purchased | 15,000 |
| Total Transaction Value | Approximately $187,000 |
| Direct Shares After Purchase | 0 |
| Indirect Shares After Purchase | 24,987,284 |
Transaction value calculated using the weighted average price reported on SEC Form 4 ($12.45 per share).
Frequently Asked Questions
-
How does this purchase compare to Lucier’s previous trading activity?
Lucier’s latest acquisition aligns with his ongoing trend of net buying. Since November 2024, he has completed 13 trades, with only one sale occurring in December 2025.
-
What effect did the purchase have on Lucier’s ownership?
This transaction increased his indirect holdings to 24,987,284 shares, while his direct ownership remains at zero. All current shares are held through trusts and related entities.
-
How significant is this purchase relative to Lucier’s total holdings?
The 15,000 shares represent just 0.06% of his total reported position prior to the transaction, further boosting his indirect stake while direct holdings remain unused.
-
Did market conditions play a role in the timing or price?
The average purchase price of $12.45 was slightly below the closing price of $12.80 on March 9, 2026. This buy comes after the stock declined 16.4% over the past year, which may have influenced the perceived value of the shares.
Company Financial Overview
| Metric | Value |
|---|---|
| Share Price (as of 3/9/26 close) | $12.80 |
| Revenue (TTM) | $3.68 billion |
| Net Income (TTM) | -$598 million |
| Dividend Yield | 5.56% |
One-year performance figures are based on data as of March 9, 2026.
About Dentsply Sirona
- Dentsply Sirona delivers a comprehensive range of dental solutions, including equipment, CAD/CAM systems, clear aligners, implants, endodontic devices, restorative materials, and consumables.
- The company’s revenue is primarily generated through sales of dental equipment and consumables, with a focus on recurring product sales and technology-driven offerings.
- Its customer base includes dental professionals, specialists, laboratories, and healthcare providers worldwide, emphasizing the professional dental sector.
As a global leader in dental technology and products, Dentsply Sirona employs around 14,000 people and offers a diverse product lineup. The company’s strategy emphasizes innovation in dental care, digital dentistry, and consumable products, supporting recurring revenue and strong customer relationships. Its competitive strength lies in its integrated product portfolio and established presence in the professional dental market.
Implications for Investors
Gregory T. Lucier’s recent purchase of 15,000 shares signals his confidence in Dentsply Sirona’s prospects. With nearly 25 million shares already under his control, this additional investment on March 9 suggests he views the current valuation as favorable.
The company’s price-to-sales ratio stands at 0.64, close to its lowest point in the past year, indicating a potentially attractive entry point for buyers.
Dentsply Sirona has faced challenges, ending 2025 with $3.4 billion in sales—a decrease from $3.8 billion the previous year. The company also reported a net loss of $598 million, largely due to a $650 million goodwill impairment.
Free cash flow dropped to $104 million in 2025 from $281 million the year before, raising concerns since free cash flow funds the company’s dividend, which currently yields over 5%.
For income-focused investors who believe free cash flow can recover, Dentsply Sirona may present an opportunity. Lucier’s increased stake suggests he expects the dividend to remain stable.
Should You Consider Buying Dentsply Sirona Shares?
Before making an investment decision, keep this in mind:
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The current rise in the US dollar could be short-lived
Stocks Rocked by Oil, Suffer 3rd-Straight Weekly Drop

Strategy (MSTR) Bought Over 4,000 Bitcoin Today via STRC As Strong Week Continues

2 Leading Technology Stocks Worth Purchasing This March

